s6y
Company name or ticker
Search
Bellerophon Therapeutics, Inc.
144
Filing for proposed sale of securities under Rule 144
Filed
Wednesday, June 7, 2023
Accession number
0001760460-23-000005
Documents
primary_doc.xml
144
On sec.gov
Filing index
All files
Complete submission text
SGML header